Skip to main content

DESARROLLO DE UNA NUEVA ESTRATEGIA TERAPEUTICA INMUNE-ESPECIFICA PARA LA ERRADICACION DEL VIH

BES-2016-076382

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Formación
Call Contratos Predoctorales
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The active human immunodeficiency virus reservoir during antiretroviral therapy: emerging players in viral persistence

  • Astorga Gamaza, Antonio
  • Buzón Gómez, María José
Marcadors cel·lulars; Virus de la immunodeficiència humana; Persistència viral, Marcadores celulares; Virus de la inmunodeficiencia humana; Persistencia viral, Cell markers; Human immunodeficiency virus; Viral persistence, Purpose of review To discuss the role of CD4+ T cells with active Human immunodeficiency virus (HIV), meaning infected cells with transcriptional and/or translational viral activity during antiretroviral therapy (ART), focusing on new technologies for its detection, potential cell markers for its characterization, and evidences on the contribution of the active HIV reservoir to long-term viral persistence. Recent findings HIV-infected cells expressing viral ribonucleic acid are systematically detected in subjects on long-term ART. In recent years, powerful new tools have provided significant insights into the nature, quantification, and identification of cells with active HIV, including the identification of new cell markers, and the presence of viral activity in specific cell populations located in different cellular and anatomical compartments. Moreover, studies on viral sequence integrity have identified cell clones with intact viral genomes and active viral transcription that could potentially persist for years. Together, new investigations support the notion that the active reservoir could represent a relevant fraction of long-term infected cells, and therefore, the study of its cell sources and mechanisms of maintenance could represent a significant advance in our understanding of viral persistence and the development of new curative strategies. Summary The presence of HIV-infected cells with viral expression during ART has been traditionally overlooked for years. Based on recent investigations, this active viral reservoir could play an important role in HIV persistence., This work was supported by the Spanish Secretariat of Science and Innovation and FEDER funds (grants SAF2015-67334-R and RTI2018-101082-B-I00 [MINECO/FEDER]), and the Fundació La Marató TV3 (grant 201805-10FMTV3). M.J.B. is supported by the Miguel Servet program funded by the Spanish Health Institute Carlos III (CP17/00179). A.A.-G. is supported by the Spanish Secretariat of Science and Innovation Ph.D. fellowship (BES-2016-076382). The funders had no role in the decision to publish or the preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir

  • Astorga Gamaza, Antonio
  • Sánchez Gaona, Nerea
  • Calvet-Mirabent, Marta
  • Gallego-Cortés, Ana
  • Rey Cano, Joan
  • Curran, Adrian
  • Grau Exposito, Judith
  • Castellvi, Josep
  • Burgos, Joaquin
  • Navarro, Jordi
  • Suanzes, Paula
  • Genescà Ferrer, Meritxell
  • Buzon, Maria Jose
  • Falcó, Vicenç
  • Perea Pérez, David
HIV infection; HIV reservoir; Immunotherapy, Infección por VIH; Reservorio de VIH; Inmunoterapia, Infecció per VIH; Reservori de VIH; Immunoteràpia, Human immunodeficiency virus (HIV) infection induces immunological dysfunction, which limits the elimination of HIV-infected cells during treated infection. Identifying and targeting dysfunctional immune cells might help accelerate the purging of the persistent viral reservoir. Here, we show that chronic HIV infection increases natural killer (NK) cell populations expressing the negative immune regulator KLRG1, both in peripheral blood and lymph nodes. Antiretroviral treatment (ART) does not reestablish these functionally impaired NK populations, and the expression of KLRG1 correlates with active HIV transcription. Targeting KLRG1 with specific antibodies significantly restores the capacity of NK cells to kill HIV-infected cells, reactivates latent HIV present in CD4+ T cells co-expressing KLRG1, and reduces the intact HIV genomes in samples from ART-treated individuals. Our data support the potential use of immunotherapy against the KLRG1 receptor to impact the viral reservoir during HIV persistence., The project leading to these results has received funding from “la Caixa” Banking Foundation under the project code LCF/PR/HR20-00218. This study was also supported by the Agencia Estatal de Investigación project PID2021-123321OB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE; The Spanish “Ministerio de Economia y Competitividad, Instituto de Salud Carlos III” (ISCIII, PI20/00160); and the Gilead fellowships GLD19/00084, GLD18/00008, GLD21-00049, and GLD22/00152. Part of the methodology was developed with the support of the grant 202104-30-31 from Fundació la Marató de TV3. M.B. is supported by the Miguel Servet program funded by the Spanish Health Institute Carlos III (CPII22/00005). A.A.-G. was supported by the Spanish Secretariat of Science and Innovation Ph.D. fellowship (BES-2016-076382). D.P. was supported by the VHIR Ph.D programme 2020. Spanish Secretariat of Science and Innovation Ph.D. fellowship. E.M.G. was supported by the Ramón y Cajal Program (RYC2018-024374-I) funded by the Spanish Secretariat of Science and Innovation, by the Comunidad de Madrid Talento Program (2017-T1/BMD-5396), and by the project PID2021-127899OB-I00 funded by MCIN /AEI /10.13039/501100011033/ FEDER, UE. We thank Dr. Joan Puñet from the flow cytometry core at the Vall d’Hebron Research Institute for his technical and scientific expertise. The funders had no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Antibody cooperative adsorption onto AuNPs and its exploitation to force natural killer cells to kill HIV-infected T cells

  • Astorga-Gamaza, Antonio|||0000-0002-1276-5276
  • Vitali, Michele|||0000-0001-8618-8988
  • Borrajo, Mireya L.
  • Suárez-López, Rosa
  • Jaime, Carlos|||0000-0002-9690-9053
  • Bastús, Neus G.|||0000-0002-3144-7986
  • Serra-Peinado, Carla|||0000-0003-1413-3990
  • Luque-Ballesteros, Laura|||0000-0001-9515-5889
  • Blanch-Lombarte, Oscar|||0000-0002-8317-7535
  • Prado, Julia G.|||0000-0002-5439-4645
  • Lorente Guerrero, Juan|||0000-0002-3264-0251
  • Pumarola, Felix|||0000-0002-7914-1695
  • Pellicer, Marc
  • Falcó, Vicenç|||0000-0001-9626-0023
  • Genescà Ferrer, Meritxell|||0000-0001-6413-3812
  • Puntes, Víctor|||0000-0001-8996-9499
  • Buzón, Maria José|||0000-0003-4427-9413
HIV represents a persistent infection which negatively alters the immune system. New tools to reinvigorate different immune cell populations to impact HIV are needed. Herein, a novel nanotool for the specific enhancement of the natural killer (NK) immune response towards HIV-infected T-cells has been developed. Bispecific Au nanoparticles (BiAb-AuNPs), dually conjugated with IgG anti-HIVgp120 and IgG anti-human CD16 antibodies, were generated by a new controlled, linker-free and cooperative conjugation method promoting the ordered distribution and segregation of antibodies in domains. The cooperatively-adsorbed antibodies fully retained the capabilities to recognize their cognate antigen and were able to significantly enhance cell-to-cell contact between HIV-expressing cells and NK cells. As a consequence, the BiAb-AuNPs triggered a potent cytotoxic response against HIV-infected cells in blood and human tonsil explants. Remarkably, the BiAb-AuNPs were able to significantly reduce latent HIV infection after viral reactivation in a primary cell model of HIV latency. This novel molecularly-targeted strategy using a bispecific nanotool to enhance the immune system represents a new approximation with potential applications beyond HIV.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir

  • Astorga Gamaza, Antonio
  • Sánchez Gaona, Nerea
  • Calvet-Mirabent, Marta
  • Gallego-Cortés, Ana
  • Rey Cano, Joan
  • Curran, Adrian
  • Grau Exposito, Judith
  • Castellvi, Josep
  • Burgos, Joaquin
  • Navarro, Jordi
  • Suanzes, Paula
  • Genescà Ferrer, Meritxell
  • Buzon, Maria Jose
  • Falcó, Vicenç
  • Perea Pérez, David
HIV infection; HIV reservoir; Immunotherapy, Infección por VIH; Reservorio de VIH; Inmunoterapia, Infecció per VIH; Reservori de VIH; Immunoteràpia, Human immunodeficiency virus (HIV) infection induces immunological dysfunction, which limits the elimination of HIV-infected cells during treated infection. Identifying and targeting dysfunctional immune cells might help accelerate the purging of the persistent viral reservoir. Here, we show that chronic HIV infection increases natural killer (NK) cell populations expressing the negative immune regulator KLRG1, both in peripheral blood and lymph nodes. Antiretroviral treatment (ART) does not reestablish these functionally impaired NK populations, and the expression of KLRG1 correlates with active HIV transcription. Targeting KLRG1 with specific antibodies significantly restores the capacity of NK cells to kill HIV-infected cells, reactivates latent HIV present in CD4+ T cells co-expressing KLRG1, and reduces the intact HIV genomes in samples from ART-treated individuals. Our data support the potential use of immunotherapy against the KLRG1 receptor to impact the viral reservoir during HIV persistence., The project leading to these results has received funding from “la Caixa” Banking Foundation under the project code LCF/PR/HR20-00218. This study was also supported by the Agencia Estatal de Investigación project PID2021-123321OB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE; The Spanish “Ministerio de Economia y Competitividad, Instituto de Salud Carlos III” (ISCIII, PI20/00160); and the Gilead fellowships GLD19/00084, GLD18/00008, GLD21-00049, and GLD22/00152. Part of the methodology was developed with the support of the grant 202104-30-31 from Fundació la Marató de TV3. M.B. is supported by the Miguel Servet program funded by the Spanish Health Institute Carlos III (CPII22/00005). A.A.-G. was supported by the Spanish Secretariat of Science and Innovation Ph.D. fellowship (BES-2016-076382). D.P. was supported by the VHIR Ph.D programme 2020. Spanish Secretariat of Science and Innovation Ph.D. fellowship. E.M.G. was supported by the Ramón y Cajal Program (RYC2018-024374-I) funded by the Spanish Secretariat of Science and Innovation, by the Comunidad de Madrid Talento Program (2017-T1/BMD-5396), and by the project PID2021-127899OB-I00 funded by MCIN /AEI /10.13039/501100011033/ FEDER, UE. We thank Dr. Joan Puñet from the flow cytometry core at the Vall d’Hebron Research Institute for his technical and scientific expertise. The funders had no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

The active human immunodeficiency virus reservoir during antiretroviral therapy: emerging players in viral persistence

  • Buzón Gómez, María José
  • Astorga Gamaza, Antonio
Marcadors cel·lulars; Virus de la immunodeficiència humana; Persistència viral, Marcadores celulares; Virus de la inmunodeficiencia humana; Persistencia viral, Cell markers; Human immunodeficiency virus; Viral persistence, Purpose of review To discuss the role of CD4+ T cells with active Human immunodeficiency virus (HIV), meaning infected cells with transcriptional and/or translational viral activity during antiretroviral therapy (ART), focusing on new technologies for its detection, potential cell markers for its characterization, and evidences on the contribution of the active HIV reservoir to long-term viral persistence. Recent findings HIV-infected cells expressing viral ribonucleic acid are systematically detected in subjects on long-term ART. In recent years, powerful new tools have provided significant insights into the nature, quantification, and identification of cells with active HIV, including the identification of new cell markers, and the presence of viral activity in specific cell populations located in different cellular and anatomical compartments. Moreover, studies on viral sequence integrity have identified cell clones with intact viral genomes and active viral transcription that could potentially persist for years. Together, new investigations support the notion that the active reservoir could represent a relevant fraction of long-term infected cells, and therefore, the study of its cell sources and mechanisms of maintenance could represent a significant advance in our understanding of viral persistence and the development of new curative strategies. Summary The presence of HIV-infected cells with viral expression during ART has been traditionally overlooked for years. Based on recent investigations, this active viral reservoir could play an important role in HIV persistence., This work was supported by the Spanish Secretariat of Science and Innovation and FEDER funds (grants SAF2015-67334-R and RTI2018-101082-B-I00 [MINECO/FEDER]), and the Fundació La Marató TV3 (grant 201805-10FMTV3). M.J.B. is supported by the Miguel Servet program funded by the Spanish Health Institute Carlos III (CP17/00179). A.A.-G. is supported by the Spanish Secretariat of Science and Innovation Ph.D. fellowship (BES-2016-076382). The funders had no role in the decision to publish or the preparation of the manuscript.